These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38323290)

  • 1. Developing new ceramide analogs against non-small cell lung cancer (NSCLC).
    Dai L; Goyal N; Liu J; Foroozesh M; Qin Z
    Am J Cancer Res; 2024; 14(1):86-96. PubMed ID: 38323290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sphingosine kinase 2 inhibitor ABC294640 displays anti-non-small cell lung cancer activities in vitro and in vivo.
    Dai L; Smith CD; Foroozesh M; Miele L; Qin Z
    Int J Cancer; 2018 May; 142(10):2153-2162. PubMed ID: 29277894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABC294640, a sphingosine kinase 2 inhibitor, enhances the antitumor effects of TRAIL in non-small cell lung cancer.
    Yang J; Yang C; Zhang S; Mei Z; Shi M; Sun S; Shi L; Wang Z; Wang Y; Li Z; Xie C
    Cancer Biol Ther; 2015; 16(8):1194-204. PubMed ID: 26054751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceramides promote apoptosis for virus-infected lymphoma cells through induction of ceramide synthases and viral lytic gene expression.
    Dai L; Trillo-Tinoco J; Bai A; Chen Y; Bielawski J; Del Valle L; Smith CD; Ochoa AC; Qin Z; Parsons C
    Oncotarget; 2015 Sep; 6(27):24246-60. PubMed ID: 26327294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ceramide glucosylation sensitizes lung cancer cells to ABC294640, a first-in-class small molecule SphK2 inhibitor.
    Guan S; Liu YY; Yan T; Zhou J
    Biochem Biophys Res Commun; 2016 Aug; 476(4):230-236. PubMed ID: 27221045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing new ceramide analogs and identifying novel sphingolipid-controlled genes against a virus-associated lymphoma.
    Chen J; Goyal N; Dai L; Lin Z; Del Valle L; Zabaleta J; Liu J; Post SR; Foroozesh M; Qin Z
    Blood; 2020 Nov; 136(19):2175-2187. PubMed ID: 32518949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Sphingosine Kinase 2 Inhibitor ABC294640 Restores the Sensitivity of BRAFV600E Mutant Colon Cancer Cells to Vemurafenib by Reducing AKT-Mediated Expression of Nucleophosmin and Translationally-Controlled Tumour Protein.
    Grbčić P; Eichmann TO; Kraljević Pavelić S; Sedić M
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer and lung injury: the dual role of ceramide.
    Goldkorn T; Chung S; Filosto S
    Handb Exp Pharmacol; 2013; (216):93-113. PubMed ID: 23563653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
    Gatt S; Dagan A
    Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-495-3p regulates sphingolipid metabolic reprogramming to induce Sphk1/ceramide mediated mitophagy and apoptosis in NSCLC.
    Arora S; Singh P; Tabassum G; Dohare R; Syed MA
    Free Radic Biol Med; 2022 Aug; 189():71-84. PubMed ID: 35853537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic, non-natural sphingolipid analogs inhibit the biosynthesis of cellular sphingolipids, elevate ceramide and induce apoptotic cell death.
    Dagan A; Wang C; Fibach E; Gatt S
    Biochim Biophys Acta; 2003 Sep; 1633(3):161-9. PubMed ID: 14499735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Sphingosine Kinase by ABC294640 against Diffuse Intrinsic Pontine Glioma (DIPG).
    Dai L; Chen J; Lin Z; Wang Z; Mu S; Qin Z
    J Cancer; 2020; 11(16):4683-4691. PubMed ID: 32626514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-338-3p suppresses cell proliferation and induces apoptosis of non-small-cell lung cancer by targeting sphingosine kinase 2.
    Zhang G; Zheng H; Zhang G; Cheng R; Lu C; Guo Y; Zhao G
    Cancer Cell Int; 2017; 17():46. PubMed ID: 28428733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination Therapy of Chloroquine and C₂-Ceramide Enhances Cytotoxicity in Lung Cancer H460 and H1299 Cells.
    Chou HL; Lin YH; Liu W; Wu CY; Li RN; Huang HW; Chou CH; Chiou SJ; Chiu CC
    Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30884764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting sphingosine kinase 1/2 by a novel dual inhibitor SKI-349 suppresses non-small cell lung cancer cell growth.
    Xue Y; Jiang K; Ou L; Shen M; Yang Y; Lu J; Xu W
    Cell Death Dis; 2022 Jul; 13(7):602. PubMed ID: 35831279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OPTIMIZATION OF SCALE-UP SYNTHESIS OF ANTI-CANCER CERAMIDE ANALOG 315.
    Foroozesh M; Goyal N; Jackson T; Do C; Booker S; Hill T; Liu J
    J Undergrad Chem Res; 2017; 16(3):89-90. PubMed ID: 30220887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Plasmodium activity of ceramide analogs.
    Labaied M; Dagan A; Dellinger M; Gèze M; Egée S; Thomas SL; Wang C; Gatt S; Grellier P
    Malar J; 2004 Dec; 3():49. PubMed ID: 15588325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin and Its Analogs in Non-Small Cell Lung Cancer Treatment: Challenges and Expectations.
    Tang C; Liu J; Yang C; Ma J; Chen X; Liu D; Zhou Y; Zhou W; Lin Y; Yuan X
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of Ceramide- and Sphingosine-Metabolizing Enzymes as Sensitizers in Radiotherapy and Chemotherapy for Head and Neck Squamous Cell Carcinoma.
    Yura Y; Masui A; Hamada M
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32722626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel agents targeting bioactive sphingolipids for the treatment of cancer.
    Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y
    Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.